ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992

Abstracts Of Papers From Therapeutic Radiology Meeting

November 21, 1975

Lines Drawn Over HHS Appropriations.

October 5, 2007

Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB

September 28, 1979